68 results
Page 2 of 4
8-K
EX-99.2
9aefj
20 Sep 21
Regulation FD Disclosure
8:01am
8-K
EX-99.3
y82vb6fv8ov2jot6q6
12 Aug 21
Synlogic Reports Second Quarter Financial Results and Provides Business Update
10:18am
8-K
EX-99.1
m3si1z7nqr dmalnvdx
15 Jul 21
Other Events
6:45am
424B5
n13rn
19 Apr 21
Prospectus supplement for primary offering
4:06pm
8-K
EX-1.1
arscwz fo
16 Apr 21
Synlogic Announces Proposed Public Offering of Common Stock
8:35am
424B5
n39lbzmdrvgm2
15 Apr 21
Prospectus supplement for primary offering
4:21pm
8-K
EX-99.2
hvxklkvnrrnndt
14 Apr 21
Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for Cancer Research (AACR) Annual Meeting
12:00am
8-K
EX-99.1
kwu j0678ta
25 Mar 21
Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
8:04am
8-K
EX-99.3
tqn5h z8h6n45qj28
25 Mar 21
Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
8:04am
8-K
EX-99.1
8k0h5h5uuk44pjg7bz
24 Mar 21
Synlogic Announces SYNB8802 Will Advance to Phase 1B Proof of Concept Study After Proof of Mechanism Demonstrated in Dietary Hyperoxaluria
4:59pm
8-K
EX-99.2
3q5xdf7lmsyx99oagkm
5 Nov 20
Synlogic Initiates Phase 1 Study of SYNB8802 for the Treatment of Enteric Hyperoxaluria
6:31am